Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

ClinicalTrials.gov ID: NCT05507216

Public ClinicalTrials.gov record NCT05507216. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinical remission in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies \[corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)\] and/or advanced therapies \[biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors\].

Study identification

NCT ID
NCT05507216
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abivax S.A.
Industry
Enrollment
636 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 25, 2023 (Actual)
Primary completion
Jun 24, 2025 (Actual)
Completion
Jul 15, 2025 (Actual)
Last update posted
Sep 10, 2026

2023 – 2025

United States locations

U.S. sites
46
U.S. states
20
U.S. cities
42
Facility City State ZIP Site status
University of Alabama -Birmingham Birmingham Alabama 35205 —
Research Solutions of Arizona, PC Litchfield Park Arizona 85340 —
Applied Research Center of Arkansas Little Rock Arkansas 72212 —
National Institute of Clinical Research Bakersfield California 93309 —
Citrus Valley Gastroenterology Covina California 91723 —
United Medical Doctors Murrieta California 92563 —
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 —
Clinical Applications Laboratories San Diego California 92103 —
Santa Maria Gastroenterology Medical Group Santa Maria California 93458 —
Danbury Hospital Danbury Connecticut 06810 —
West Central Gastroenterology d/b/a Gastro Florida Clearwater Florida 33762 —
IHS Health Kissimmee Florida 34741 —
Research Associates of South Florida Miami Florida 33134 —
Sanchez Clinical Research, Inc Miami Florida 33157 —
Wellness Clinical Research Miami Lakes Florida 33016 —
Sarkis Clinical Trials - Parent Ocala Florida 34474 —
AdventHealth Medical Group Orlando Florida 32804 —
Arnold Palmer Hospital For Children Orlando Florida 32806 —
Omega Research Orlando, LLC Orlando Florida 32808 —
Advanced Medical Research Center Port Orange Florida 32127 —
GCP Clinical Research, LLC Tampa Florida 33609 —
University of South Florida - PARENT Tampa Florida 33612 —
The University of Iowa Iowa City Iowa 52242 —
Cotton O'Neil Clinical Research Center Topeka Kansas 66606 —
Tandem Clinical Research, LLC Marrero Louisiana 70072 —
University of Michigan Ann Arbor Michigan 48109 —
Clinical Research Institute of Michigan, LLC Chesterfield Michigan 48047 —
BVL Clinical Research Liberty Missouri 64068 —
Premier Health Research Sparta New Jersey 07871 —
NY Scientific Corp. Brooklyn New York 11235 —
Mount Sinai New York New York 10029 —
Plains Clinical Research Center, LLC Fargo North Dakota 58104 —
Susquehanna Research Group, LLC Harrisburg Pennsylvania 17110 —
Frontier Clinical Research, LLC Uniontown Pennsylvania 15401 —
Rapid City Medical Center, LLC Rapid City South Dakota 57701 —
Digestive Health Research, LC Hermitage Tennessee 37076 —
Texas Clinical Research Institute, LLC Arlington Texas 76012 —
Inquest Clinical Research Baytown Texas 77521 —
Gastroenterology Consultants of South Texas, PA Harlingen Texas 78550 —
Digestive System Healthcare Pasadena Texas 77505 —
LinQ Research, LLC Pearland Texas 77584 —
Southern Star Research Institute, LLC San Antonio Texas 78229 —
Tyler Research Institute, LLC Tyler Texas 75703 —
Richmond VA Medical Center Richmond Virginia 23249 —
Gastroenterology Consultants and Endoscopy Center of Southwest Virginia Roanoke Virginia 24014 —
The Vancouver Clinic Vancouver Washington 98664 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 216 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05507216, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 10, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05507216 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →